[HTML][HTML] Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles

A Yaghmur, H Mu - Acta Pharmaceutica Sinica B, 2021 - Elsevier
The use of lipid nanocarriers for drug delivery applications is an active research area, and a
great interest has particularly been shown in the past two decades. Among different lipid …

Cubosomes and hexosomes as novel nanocarriers for bioactive compounds

C Tan, SF Hosseini, SM Jafari - Journal of Agricultural and Food …, 2022 - ACS Publications
Cubosomes and hexosomes are nanostructured liquid crystalline particles, known as
biocompatible nanocarriers for drug delivery. In recent years, there has been good interest …

[HTML][HTML] Cubosomes in cancer drug delivery: A review

R Varghese, S Salvi, P Sood, B Kulkarni… - Colloid and Interface …, 2022 - Elsevier
The lyotropic nonlamellar liquid crystalline nanoparticles (LCNs), especially cubosomes are
gaining utility and acceptance as a drug delivery system, in diseases like cancer. These …

Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy

MS Sharafshadeh, F Tafvizi, P Khodarahmi… - International Journal of …, 2023 - Elsevier
Alginate (AL), in the form of a hydrogel, is extensively used in drug delivery. In the current
study, an optimum formulation of alginate-coated niosome-based nanocarriers for co …

Advances in the design of ph-sensitive cubosome liquid crystalline nanocarriers for drug delivery applications

O Mertins, PD Mathews, A Angelova - Nanomaterials, 2020 - mdpi.com
Nanostructure bicontinuous cubic phase self-assembled materials are receiving expanding
applications as biocompatible delivery systems in various therapeutic fields. The …

Rapidly dissolving microneedles for the delivery of cubosome-like liquid crystalline nanoparticles with sustained release of rapamycin

A Ramalheiro, JL Paris, BFB Silva, LR Pires - International Journal of …, 2020 - Elsevier
In this study, we developed a system for the transdermal delivery and controlled release of
the hydrophobic immunosuppressive drug rapamycin, foreseeing an application in psoriasis …

[HTML][HTML] Omega-3 fatty acid nanocarriers: Characterization and potential applications

A Yaghmur, S Ghayas, H Jan, GD Kalaycioglu… - Current Opinion in …, 2023 - Elsevier
Lyotropic non-lamellar liquid crystalline (LLC) nano-self-assemblies (including cubosomes
and hexosomes) are attractive versatile platforms for encapsulation and delivery of drugs …

Tumor microenvironment and nanotherapeutics: intruding the tumor fort

AVVVR Kiran, GK Kumari, PT Krishnamurthy… - Biomaterials …, 2021 - pubs.rsc.org
Over recent years, advancements in nanomedicine have allowed new approaches to
diagnose and treat tumors. Nano drug delivery systems exploit the enhanced permeability …

Cubosomal lipid nanoassemblies with pH-sensitive shells created by biopolymer complexes: A synchrotron SAXS study

PD Mathews, O Mertins, B Angelov… - Journal of Colloid and …, 2022 - Elsevier
We report a strategy for sustainable development of pH-responsive cubic liquid crystalline
nanoparticles (cubosomes), in which the structure-defining lyotropic nonlamellar lipid and …

Recent advances of non-lamellar lyotropic liquid crystalline nanoparticles in nanomedicine

S Murgia, S Biffi, R Mezzenga - Current opinion in colloid & interface …, 2020 - Elsevier
Non-lamellar lyotropic liquid crystalline nanocarriers such as hexosomes and cubosomes
are relatively unexplored lipid-based nanoparticles in nanomedicine that can be specifically …